In contrast, spatial habitat analysis focuses on features from distinct subregions within the tumor, rather than treating the tumor as a homogeneous entity.[17, 18] This approach is based on the premise that intra‐tumor heterogeneity strongly influences treatment response and changes during NAT. The gene discussed is BRD2; the disease is neoplasm.